These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 17605005

  • 41. The effects of licit and illicit recreational drugs on prospective memory: a meta-analytic review.
    Platt B, O'Driscoll C, Curran VH, Rendell PG, Kamboj SK.
    Psychopharmacology (Berl); 2019 Apr; 236(4):1131-1143. PubMed ID: 31093722
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
    Gouzoulis-Mayfrank E, Daumann J.
    J Psychopharmacol; 2006 Mar; 20(2):188-93. PubMed ID: 16510477
    [Abstract] [Full Text] [Related]

  • 45. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC.
    J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
    [Abstract] [Full Text] [Related]

  • 46. Deterioration of executive functioning in chronic ecstasy users; evidence for multiple drugs effects.
    Verbaten MN.
    Curr Drug Abuse Rev; 2010 Sep; 3(3):129-38. PubMed ID: 21054259
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Persistent nigrostriatal dopaminergic abnormalities in ex-users of MDMA ('Ecstasy'): an 18F-dopa PET study.
    Tai YF, Hoshi R, Brignell CM, Cohen L, Brooks DJ, Curran HV, Piccini P.
    Neuropsychopharmacology; 2011 Mar; 36(4):735-43. PubMed ID: 21160467
    [Abstract] [Full Text] [Related]

  • 50. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems.
    Parrott AC, Milani RM, Parmar R, Turner JD.
    Psychopharmacology (Berl); 2001 Dec; 159(1):77-82. PubMed ID: 11797073
    [Abstract] [Full Text] [Related]

  • 51. Basal functioning of the hypothalamic-pituitary-adrenal (HPA) axis and psychological distress in recreational ecstasy polydrug users.
    Wetherell MA, Montgomery C.
    Psychopharmacology (Berl); 2014 Apr; 231(7):1365-75. PubMed ID: 24190587
    [Abstract] [Full Text] [Related]

  • 52. Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use.
    Hanson KL, Luciana M.
    Psychol Med; 2004 Feb; 34(2):229-46. PubMed ID: 14982129
    [Abstract] [Full Text] [Related]

  • 53. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
    Reay JL, Hamilton C, Kennedy DO, Scholey AB.
    J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
    [Abstract] [Full Text] [Related]

  • 54. Contribution of cannabis and MDMA ("ecstasy") to cognitive changes in long-term polydrug users.
    Dafters RI, Hoshi R, Talbot AC.
    Psychopharmacology (Berl); 2004 May; 173(3-4):405-10. PubMed ID: 12955295
    [Abstract] [Full Text] [Related]

  • 55. Cognitive performance in light current users and ex-users of ecstasy (MDMA) and controls.
    Golding JF, Groome DH, Rycroft N, Denton Z.
    Am J Drug Alcohol Abuse; 2007 May; 33(2):301-7. PubMed ID: 17497553
    [Abstract] [Full Text] [Related]

  • 56. Discrete memory impairments in largely pure chronic users of MDMA.
    Wunderli MD, Vonmoos M, Fürst M, Schädelin K, Kraemer T, Baumgartner MR, Seifritz E, Quednow BB.
    Eur Neuropsychopharmacol; 2017 Oct; 27(10):987-999. PubMed ID: 28866005
    [Abstract] [Full Text] [Related]

  • 57. N-acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: a 3 T magnetic resonance spectroscopy study.
    Cowan RL, Joers JM, Dietrich MS.
    Pharmacol Biochem Behav; 2009 Mar; 92(1):105-10. PubMed ID: 19032963
    [Abstract] [Full Text] [Related]

  • 58. Electrophysiological indices of altered working memory processes in long-term ecstasy users.
    Nulsen C, Fox A, Hammond G.
    Hum Psychopharmacol; 2011 Oct; 26(7):488-97. PubMed ID: 21953632
    [Abstract] [Full Text] [Related]

  • 59. The impact of regular ecstasy use on memory function.
    Simon NG, Mattick RP.
    Addiction; 2002 Dec; 97(12):1523-9. PubMed ID: 12472636
    [Abstract] [Full Text] [Related]

  • 60. Cognitive deficits and cognitive normality in recreational cannabis and Ecstasy/MDMA users.
    Parrott A.
    Hum Psychopharmacol; 2003 Mar; 18(2):89-90. PubMed ID: 12590401
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.